High Performance GP-Based Approach for fMRI Big Data Classification

Amirhessam Tahmassebi; Amir Gandomi; Anke Meyer‐Baese

doi:10.1145/3093338.3104145

Abstract

1 min read

We consider resting-state Functional Magnetic Resonance Imaging (fMRI) of two classes of patients: one that took the drug N-acetylcysteine (NAC) and the other one a placebo before and after a smoking cessation treatment. Our goal was to classify the relapse in nicotine-dependent patients as treatment or non-treatment based on their fMRI scans. 80% accuracy was obtained using Independent Component Analysis (ICA) along with Genetic Programming (GP) classifier using High Performance Computing (HPC) which we consider significant enough to suggest that there is a difference in the resting-state fMRI images of a smoker that undergoes this smoking cessation treatment compared to a smoker that receives a placebo.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2017

An evolutionary approach for fMRI big data classification

Amirhessam Tahmassebi, Amir Gandomi, Ian McCann, Mieke H.J. Schulte, Lianne Schmaal, Anna E. Goudriaan, Anke Meyer‐Baese

2022 IEEE Congress on Evolutionary Computation (CEC)

Article2018

Optimized Naive‐Bayes and Decision Tree Approaches for fMRI Smoking Cessation Classification

Amirhessam Tahmassebi, Amir Gandomi, Mieke H.J. Schulte, Anna E. Goudriaan, Simon Y. Foo, Anke Meyer‐Baese

Complexity

Article2018

Deep Learning in Medical Imaging

Amirhessam Tahmassebi, Amir Gandomi, Ian McCann, Mieke H.J. Schulte, Anna E. Goudriaan, Anke Meyer‐Baese

Proceedings of the Practice and Experience on Advanced Research Computing

Article2015

<i>N</i>-acetylcysteine for therapy-resistant tobacco use disorder: a pilot study

Eduardo Seixas Prado, Michael Maes, Luiz Gustavo Piccoli, Marcela M. Baracat, Décio Sabattini Barbosa, Olavo Franco, Seetal Dodd, Michael Berk, Sandra Odebrecht Vargas Nunes

Article2009

N-acetylcysteine as adjunctive treatment in severe malaria: A randomized, double-blinded placebo-controlled clinical trial*

Prakaykaew Charunwatthana, Maryam Faiz, Ronnatrai Ruangveerayut, Richard J. Maude, Mushfiqur Rahman, L. Jackson Roberts, Kevin Moore, Emran Bin Yunus, M. Gofranul Hoque, Mahatab Uddin Hasan, Sue J. Lee, Sasithon Pukrittayakamee, Paul N. Newton, Sir Nicholas White, Nicholas Day, Arjen M. Dondorp

Critical Care Medicine